Aethlon Initiates Patient Enrollment of Hepatitis C Clinical Studies

Aethlon Medical, Inc. announced Thursday it has established primary clinical endpoints and clarified efficacy assessments related to a study that will evaluate the use of the Aethlon Hemopurifier in combination with standard of care [hepatitis C] drug therapy.
CNBC